878 related articles for article (PubMed ID: 30415450)
1. Epidemiological, Clinical and Outcome Aspects of Patients with Cryptococcosis Caused by Cryptococcus gattii from a Non-endemic Area of Brazil.
Damasceno-Escoura AH; de Souza ML; de Oliveira Nunes F; Pardi TC; Gazotto FC; Florentino DH; Mora DJ; Silva-Vergara ML
Mycopathologia; 2019 Feb; 184(1):65-71. PubMed ID: 30415450
[TBL] [Abstract][Full Text] [Related]
2. Fatal Cryptococcus gattii genotype AFLP6/VGII infection in a HIV-negative patient: case report and a literature review.
Favalessa OC; Lázera Mdos S; Wanke B; Trilles L; Takahara DT; Tadano T; Dias LB; Vieira AC; Novack GV; Hahn RC
Mycoses; 2014 Oct; 57(10):639-43. PubMed ID: 24980291
[TBL] [Abstract][Full Text] [Related]
3. Molecular typing and in vitro antifungal susceptibility of Cryptococcus spp from patients in Midwest Brazil.
Favalessa OC; de Paula DA; Dutra V; Nakazato L; Tadano T; Lazera Mdos S; Wanke B; Trilles L; Walderez Szeszs M; Silva D; Hahn RC
J Infect Dev Ctries; 2014 Aug; 8(8):1037-43. PubMed ID: 25116671
[TBL] [Abstract][Full Text] [Related]
4. Microbiological characteristics of clinical isolates of Cryptococcus spp. in Bahia, Brazil: molecular types and antifungal susceptibilities.
Matos CS; de Souza Andrade A; Oliveira NS; Barros TF
Eur J Clin Microbiol Infect Dis; 2012 Jul; 31(7):1647-52. PubMed ID: 22278291
[TBL] [Abstract][Full Text] [Related]
5. Genotypes of Cryptococcus neoformans and Cryptococcus gattii as agents of endemic cryptococcosis in Teresina, Piauí (northeastern Brazil).
Martins LM; Wanke B; Lazéra Mdos S; Trilles L; Barbosa GG; Macedo RC; Cavalcanti Mdo A; Eulálio KD; Castro JA; Silva AS; Nascimento FF; Gouveia VA; Monte SJ
Mem Inst Oswaldo Cruz; 2011 Sep; 106(6):725-30. PubMed ID: 22012227
[TBL] [Abstract][Full Text] [Related]
6. Molecular characterization of clinical and environmental isolates from the Cryptococcus neoformans/C. Gattii species complexes of Maceió, Alagoas, Brazil.
de Holanda Fonseca DL; Silva DMWD; de Albuquerque Maranhão FC
Braz J Microbiol; 2024 Jun; 55(2):1369-1380. PubMed ID: 38619732
[TBL] [Abstract][Full Text] [Related]
7. Molecular types of Cryptococcus gattii/Cryptococcus neoformans species complex from clinical and environmental sources in Nairobi, Kenya.
Kangogo M; Bader O; Boga H; Wanyoike W; Folba C; Worasilchai N; Weig M; Groß U; Bii CC
Mycoses; 2015 Nov; 58(11):665-70. PubMed ID: 26404188
[TBL] [Abstract][Full Text] [Related]
8. Molecular typing, in vitro susceptibility and virulence of Cryptococcus neoformans/Cryptococcus gattii species complex clinical isolates from south-eastern Brazil.
Grizante Barião PH; Tonani L; Cocio TA; Martinez R; Nascimento É; von Zeska Kress MR
Mycoses; 2020 Dec; 63(12):1341-1351. PubMed ID: 32869413
[TBL] [Abstract][Full Text] [Related]
9. Central nervous system infection due to Cryptococcus gattii sensu lato in India: Analysis of clinical features, molecular profile and antifungal susceptibility.
Lahiri Mukhopadhyay S; Bahubali VH; Manjunath N; Swaminathan A; Maji S; Palaniappan M; Parthasarathy S; Chandrashekar N
Mycoses; 2017 Nov; 60(11):749-757. PubMed ID: 28736880
[TBL] [Abstract][Full Text] [Related]
10. Cryptococcal meningitis in non-HIV patients in the State of Amazonas, Northern Brazil.
Pinheiro SB; Sousa ES; Cortez ACA; da Silva Rocha DF; Menescal LSF; Chagas VS; Gómez ASP; Cruz KS; Santos LO; Alves MJ; Matsuura ABJ; Wanke B; Trilles L; Frickmann H; de Souza JVB
Braz J Microbiol; 2021 Mar; 52(1):279-288. PubMed ID: 33025379
[TBL] [Abstract][Full Text] [Related]
11. Molecular epidemiology and in vitro antifungal susceptibility testing of 108 clinical Cryptococcus neoformans sensu lato and Cryptococcus gattii sensu lato isolates from Denmark.
Hagen F; Hare Jensen R; Meis JF; Arendrup MC
Mycoses; 2016 Sep; 59(9):576-84. PubMed ID: 27061834
[TBL] [Abstract][Full Text] [Related]
12. Genotype and mating type distribution within clinical Cryptococcus neoformans and Cryptococcus gattii isolates from patients with cryptococcal meningitis in Uberaba, Minas Gerais, Brazil.
Mora DJ; Pedrosa AL; Rodrigues V; Leite Maffei CM; Trilles L; Dos Santos Lazéra M; Silva-Vergara ML
Med Mycol; 2010 Jun; 48(4):561-9. PubMed ID: 19905964
[TBL] [Abstract][Full Text] [Related]
13. Primary endemic Cryptococcosis gattii by molecular type VGII in the state of Pará, Brazil.
Santos WR; Meyer W; Wanke B; Costa SP; Trilles L; Nascimento JL; Medeiros R; Morales BP; Bezerra Cde C; Macêdo RC; Ferreira SO; Barbosa GG; Perez MA; Nishikawa MM; Lazéra Mdos S
Mem Inst Oswaldo Cruz; 2008 Dec; 103(8):813-8. PubMed ID: 19148422
[TBL] [Abstract][Full Text] [Related]
14. Molecular epidemiology reveals genetic diversity among 363 isolates of the Cryptococcus neoformans and Cryptococcus gattii species complex in 61 Ivorian HIV-positive patients.
Kassi FK; Drakulovski P; Bellet V; Krasteva D; Gatchitch F; Doumbia A; Kouakou GA; Delaporte E; Reynes J; Mallié M; Menan HIE; Bertout S
Mycoses; 2016 Dec; 59(12):811-817. PubMed ID: 27461533
[TBL] [Abstract][Full Text] [Related]
15. Molecular characterisation and antifungal susceptibility of clinical Cryptococcus deuterogattii (AFLP6/VGII) isolates from Southern Brazil.
Herkert PF; Hagen F; de Oliveira Salvador GL; Gomes RR; Ferreira MS; Vicente VA; Muro MD; Pinheiro RL; Meis JF; Queiroz-Telles F
Eur J Clin Microbiol Infect Dis; 2016 Nov; 35(11):1803-1810. PubMed ID: 27477855
[TBL] [Abstract][Full Text] [Related]
16. Clinical, epidemiological and outcome features of patients with cryptococcosis in Uberaba, Minas Gerais, Brazil.
Mora DJ; da Cunha Colombo ER; Ferreira-Paim K; Andrade-Silva LE; Nascentes GA; Silva-Vergara ML
Mycopathologia; 2012 Jun; 173(5-6):321-7. PubMed ID: 22130645
[TBL] [Abstract][Full Text] [Related]
17. Molecular epidemiology reveals genetic diversity amongst isolates of the Cryptococcus neoformans/C. gattii species complex in Thailand.
Kaocharoen S; Ngamskulrungroj P; Firacative C; Trilles L; Piyabongkarn D; Banlunara W; Poonwan N; Chaiprasert A; Meyer W; Chindamporn A
PLoS Negl Trop Dis; 2013; 7(7):e2297. PubMed ID: 23861989
[TBL] [Abstract][Full Text] [Related]
18. Cryptococcosis by Cryptococcus neoformans/Cryptococcus gattii Species Complexes in non-HIV-Infected Patients in Southeastern Brazil.
Nascimento E; Barião PHG; Kress MRVZ; Vilar FC; Santana RC; Gaspar GG; Martinez R
Rev Soc Bras Med Trop; 2021; 54():e01692021. PubMed ID: 34495255
[TBL] [Abstract][Full Text] [Related]
19. Molecular types of Cryptococcus neoformans and Cryptococcus gattii in Western Australia and correlation with antifungal susceptibility.
Lee GA; Arthur I; Merritt A; Leung M
Med Mycol; 2019 Nov; 57(8):1004-1010. PubMed ID: 30649538
[TBL] [Abstract][Full Text] [Related]
20. Comparative antifungal susceptibility analyses of Cryptococcus neoformans VNI and Cryptococcus gattii VGII from the Brazilian Amazon Region by the Etest, Vitek 2, and the Clinical and Laboratory Standards Institute broth microdilution methods.
Nishikawa MM; Almeida-Paes R; Brito-Santos F; Nascimento CR; Fialho MM; Trilles L; Morales BP; da Silva SA; Santos W; Santos LO; Fortes ST; Cardarelli-Leite P; Lázera MDS
Med Mycol; 2019 Oct; 57(7):864-873. PubMed ID: 30657975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
